366 related articles for article (PubMed ID: 25491240)
1. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.
Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):292-300. PubMed ID: 25829248
[TBL] [Abstract][Full Text] [Related]
3. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
4. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
[TBL] [Abstract][Full Text] [Related]
7. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
Freemantle N; Lafuente-Lafuente C; Mitchell S; Eckert L; Reynolds M
Europace; 2011 Mar; 13(3):329-45. PubMed ID: 21227948
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cost-effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia.
Tesic D; Kostic M; Paunovic D; Jankovic SM
Kardiol Pol; 2015; 73(4):287-95. PubMed ID: 25428811
[TBL] [Abstract][Full Text] [Related]
9. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
[TBL] [Abstract][Full Text] [Related]
10. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
Humphries KH; Kerr CR; Steinbuch M; Dorian P;
CMAJ; 2004 Sep; 171(7):741-5. PubMed ID: 15451836
[TBL] [Abstract][Full Text] [Related]
11. The effect of antiarrhythmic medications on the risk of cardiovascular outcomes in patients with atrial fibrillation and coronary artery disease.
Wang SR; Huang KC; Lin TT; Chuang SL; Yang YY; Wu CK; Lin LY
Int J Cardiol; 2024 Aug; 409():132198. PubMed ID: 38782070
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
[TBL] [Abstract][Full Text] [Related]
13. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
[TBL] [Abstract][Full Text] [Related]
14. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
Friberg L
Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
[TBL] [Abstract][Full Text] [Related]
15. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Frommeyer G; Milberg P; Uphaus T; Kaiser D; Kaese S; Breithardt G; Eckardt L
Cardiovasc Ther; 2013 Dec; 31(6):e63-71. PubMed ID: 23647657
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
Kosior D; Opolski G; Torbicki A
Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
[TBL] [Abstract][Full Text] [Related]
19. Limited duration of antiarrhythmic drug use for newly diagnosed atrial fibrillation in a nationwide population under age 65.
D'Angelo RN; Rahman M; Khanna R; Yeh RW; Goldstein L; Yadalam S; Kalsekar I; Tung P; Zimetbaum PJ
J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1529-1537. PubMed ID: 33760297
[TBL] [Abstract][Full Text] [Related]
20. The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014.
Hayward C; Patel HC; Patel K; Di Mario C; Lyon AR; Ahsan SY; Rowland E
Eur Heart J Cardiovasc Pharmacother; 2016 Apr; 2(2):90-4. PubMed ID: 27418969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]